Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women.

Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. Abstract Text:

Waljit S Dhillo,Owais B Chaudhri,Emily L Thompson,Kevin G Murphy,Michael Patterson,Radha Ramachandran,Gurjinder K Nijher,Vian Amber,Alexander Kokkinos,Mandy Donaldson,Mohammad A Ghatei,Stephen R Bloom,

CONTEXT: Kisspeptin, the endogenous ligand of the G protein-coupled receptor 54, is a key regulator of the hypothalamo-pituitary-gonadal (HPG) axis. GPR54-null mice exhibit reproductive dysfunction, and exogenous kisspeptin potently stimulates the HPG axis in rodents, primates, and human males. The effects of kisspeptin administration to human females are unknown. OBJECTIVE: Our objective was to investigate the effects of kisspeptin on LH release during the menstrual cycle in female volunteers. DESIGN: Bolus sc kisspeptin-54 was administered to female volunteers, and plasma gonadotropins were measured. SETTING: The study took place at a hospital clinical research facility. VOLUNTEERS: Subjects were healthy female volunteers with regular menstrual cycles. Intervention: 1) Volunteers received a sc bolus injection of kisspeptin-54 (0, 0.2, 0.4, 0.8, 1.6, 3.2, and 6.4 nmol/kg; n = 3-4 per dose) in the follicular phase; and 2) volunteers (n = 8) received a sc bolus injection of either kisspeptin-54 (0.4 nmol/kg) or saline in random order during each phase of the menstrual cycle. MAIN OUTCOME MEASURES: Plasma gonadotropins were measured. RESULTS: 1) Kisspeptin-54 caused a dose-dependent increase in mean LH over time at doses from 0.2-6.4 nmol/kg. 2) Kisspeptin-54 increased plasma LH compared with saline injection in all phases of the cycle. The effect of kisspeptin was greatest in the preovulatory phase and least in the follicular phase of the cycle [mean increase in LH over baseline (IU/liter) +/- sem for follicular phase was 0.12 +/- 0.17; preovulatory phase, 20.64 +/- 2.91 (P < 0.001 vs. follicular phase); luteal phase, 2.17 +/- 0.79 (P < 0.01 vs. follicular phase)]. CONCLUSION: Elevation of plasma kisspeptin in human females potently stimulates LH release in the preovulatory phase and provides a novel mechanism for manipulation of the HPG axis in women.

Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. Publishing Authors By Initials

WS Dhillo,OB Chaudhri,EL Thompson,KG Murphy,M Patterson,R Ramachandran,GK Nijher,V Amber,A Kokkinos,M Donaldson,MA Ghatei,SR Bloom,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: The Journal of clinical endocrinology and metaboli

VOLUME: 92

Page Numbers: 3958-66

Journal Abbreviation: J. Clin. Endocrinol. Metab.

ISSN: 0021-972X

DAY: 17

MONTH: 07

YEAR: 2007

Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 375362

Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women.

AFFILIATION: Department of Metabolic Medicine, Imperial College London, 6th Floor Commonwealth Building, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom.

Country: United States

AGENCY: United Kingdom Wellcome T

GRANT:

ACRONYM:

MEDLINETA: J Clin Endocrinol Metab

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women Related Publications

• A function for the psi subunit in loading the Escherichia coli DNA polymerase sliding clamp.
• Angina in a 41-year-old man with a congenital coronary abnormality and cardiac surgery 27 years earlier.
• Beyond beta-blockade: nerve growth factor and arrhythmia.
• Body image and sexual problems in young women with breast cancer.
• Capitation and racial and ethnic differences in use and cost of public mental health services.
• Centromere dynamics.
• Children prefer certain individuals over perfect duplicates.
• Counting kinetochore protein numbers in budding yeast using genetically encoded fluorescent proteins.
• Creating a medical, ethical, and legal framework for complex living kidney donors.
• Dermatologic problems in the allergic child.
• Developmental changes in the understanding of generics.
• IQGAP1 regulates cell motility by linking growth factor signaling to actin assembly.
• Identification of Anthranilic Acid Derivatives as a Novel Class of Allosteric Inhibitors of Hepatitis C NS5B Polymerase.
• Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women.
• Lay health advisor interventions among Hispanics/Latinos: a qualitative systematic review.
• Loss of nails, associated with alopecia cicatrisata and alopecia areata.
• Microtubule dynamics in the budding yeast mating pathway.
• Natural experimental models of thrombophlebitis.
• Oxyntomodulin : a novel potential treatment for obesity.
• Pericentric chromatin is an elastic component of the mitotic spindle.
• Pre-steady-state kinetic characterization of the AP endonuclease activity of human AP endonuclease 1.
• Social evaluation by preverbal infants.
• Social networks and their relationship to mental health service use and expenditures among Medicaid beneficiaries.
• Sustainable health: a new dimension of sustainability science.
• Tau-dependent microtubule disassembly initiated by prefibrillar beta-amyloid.
• The control of the adaptation of the human neonate to postnatal nutrition.
• The evolution of the american law institute test for insanity in Oregon: focus on diagnosis.
• The origins of cognitive dissonance: evidence from children and monkeys.
• Transplant-associated hyperglycemia: a new look at an old problem.
• Two-year-olds use artist intention to understand drawings.